Lupron depot and Bone density abnormal - a phase IV clinical study of FDA data
Summary:
Bone density abnormal is reported as a side effect among people who take Lupron depot (leuprolide acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Creon, and have Breast cancer.
The phase IV clinical study analyzes which people have Bone density abnormal when taking Lupron depot. It is created by eHealthMe based on reports of 26,734 people who have side effects when taking Lupron depot from the FDA, and is updated regularly.
What is Lupron depot?
Lupron depot has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 27,037 Lupron depot users. Check the latest studies of Lupron depot.
What is Bone density abnormal?
Bone density abnormal is found to be associated with 247 drugs and 252 conditions by eHealthMe. Check the latest studies of Bone density abnormal.
26,734 people reported to have side effects when taking Lupron depot.
Among them, 12 people (0.04%) have Bone density abnormal.
Among these 12 people:
How long have people been on Lupron depot when they have Bone density abnormal? *
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 50 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Bone density abnormal when taking Lupron depot? *
- female: 66.67 %
- male: 33.33 %
What is the age of people who have Bone density abnormal when taking Lupron depot? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 25 %
- 20-29: 25 %
- 30-39: 25 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 25 %
What are other drugs people take besides Lupron depot? *
- Topamax: 1 person, 8.33%
- Prolia: 1 person, 8.33%
- Prilosec: 1 person, 8.33%
- Maxalt: 1 person, 8.33%
- Erleada: 1 person, 8.33%
- Creon: 1 person, 8.33%
What are other side effects people have besides Bone density abnormal? *
- Muscle Atrophy (a decrease in the mass of the muscle): 3 people, 25.00%
- Weight Increased: 2 people, 16.67%
- Sleep Disorder: 2 people, 16.67%
- Gynecomastia (enlargement of the gland tissue of the male breast): 2 people, 16.67%
- Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 16.67%
- Feeling Abnormal: 2 people, 16.67%
- Fatigue (feeling of tiredness): 2 people, 16.67%
- Hyperhidrosis (abnormally increased sweating): 2 people, 16.67%
- Hot Flush (sudden feelings of heat): 2 people, 16.67%
- Vitamin B12 Decreased: 2 people, 16.67%
What are the existing conditions these people have? *
- Breast Cancer: 2 people, 16.67%
- Migraine (headache): 1 person, 8.33%
- Insomnia (sleeplessness): 1 person, 8.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Lupron depot and have Bone density abnormal?
- Check whether Bone density abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lupron depot:
- Lupron depot (27,037 reports)
Bone density abnormal treatments and more:
- Bone density abnormal (7,126 reports)
How severe was Bone density abnormal and when was it recovered:
Expand to all the drugs that have ingredients of leuprolide acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lupron depot:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bone density abnormal:
- Bone density abnormal (247 drugs)
Browse all the conditions that are associated with Bone density abnormal:
- Bone density abnormal (252 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Lupron depot) and Lupron depot (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Novolin N cause Anaemia? - 6 seconds ago
- Weight Loss and Stroke - 6 seconds ago
- Could Gabapentin cause Embolism Venous? - 7 seconds ago
- Could Indapamide cause Bleeding Into The Skin? - 8 seconds ago
- Could Flonase cause Heart Palpitations? - 14 seconds ago
- Drug interactions of Colestid and Depakote - 20 seconds ago
- Could Clonidine cause Drooling? - 20 seconds ago
- Drug interactions of Cimzia and Chloraprep One-Step - 29 seconds ago
- Drug interactions of Novolog and Vitamin D2 - 29 seconds ago
- Drug interactions of Losartan and Micafungin Sodium - 29 seconds ago